Wendell David Associates Inc Pfizer Inc Transaction History

Wendell David Associates Inc

$1.05 Billion
Q3 2024

A detailed history of Wendell David Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wendell David Associates Inc holds 59,482 shares of PFE stock, worth $1.49 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

59,482

Previous 58,293 2.04%

Holding current value

$1.49 Million

Previous $1.63 Million 5.52%

% of portfolio

0.16%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$27.7 - $31.39 $32,935 - $37,322	1,189 Added 2.04%	59,482 $1.72 Million
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $10,104 - $11,840	400 Added 0.69%	58,293 $1.63 Million
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $62,498 - $71,768	-2,414 Reduced 4.0%	57,893 $1.61 Million
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $91,231 - $106,640	2,843 Added 4.95%	60,307 $2 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $1,083 - $1,253	-30 Reduced 0.05%	57,464 $2.11 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $48,449 - $63,074	1,230 Added 2.19%	57,494 $2.35 Million
Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $20,040 - $26,160	480 Added 0.86%	56,264 $2.88 Million
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $15,316 - $18,697	350 Added 0.63%	55,784 $2.44 Million
Q2 2022 Jul 14, 2022	SELL	$46.53 - $55.17 $837 - $993	-18 Reduced 0.03%	55,434 $2.91 Million
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $743 - $1,102	18 Added 0.03%	55,452 $3.27 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $26,792 - $30,216	-800 Reduced 1.42%	55,434 $2.01 Million
Q4 2020 Jan 22, 2021	BUY	$33.47 - $42.56 $4,250 - $5,405	127 Added 0.23%	56,234 $2.07 Million
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $31,750 - $37,250	1,000 Added 1.81%	56,107 $2.06 Million
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $46,707 - $66,735	-1,728 Reduced 3.04%	55,107 $1.8 Million
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $32,920 - $37,360	-1,000 Reduced 1.73%	56,835 $2.23 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $48,897 - $63,405	1,505 Added 2.67%	57,835 $2.08 Million
Q2 2019 Jul 16, 2019	SELL	$36.98 - $41.52 $13,756 - $15,445	-372 Reduced 0.66%	56,330 $2.44 Million
Q1 2019 Apr 11, 2019	SELL	$37.5 - $41.2 $41,662 - $45,773	-1,111 Reduced 1.92%	56,702 $2.41 Million
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $7,694 - $8,772	200 Added 0.35%	57,813 $2.52 Million
Q2 2018 Jul 16, 2018	BUY	$32.98 - $35.16 $44,951 - $47,923	1,363 Added 2.42%	57,613 $2.09 Million
Q1 2018 Apr 11, 2018	SELL	$31.91 - $37.02 $78,594 - $91,180	-2,463 Reduced 4.19%	56,250 $2 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $9,978 - $10,587	-300 Reduced 0.51%	58,713 $2.13 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $1.83 Million - $2.02 Million	59,013	59,013 $2.11 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Pfizer Inc Transaction History